Szalóki Tibor, Tóth Veronika, Tiszlavicz László, Czakó László
Jávorszky Odön Kórház Gastroenterológiai Osztály, Vác.
Orv Hetil. 2006 Mar 19;147(11):501-7.
EMR is a widely used treatment option for gastric adenoma and early gastric cancer, but, there are no data on its use in Hungary. The aim of this study was to assess the diagnostic and therapeutic efficacy of EMR.
44 patients (30 females, 14 males, mean age: 67 years) were studied between 1994 and 2005; 33 had severe concomitant diseases (liver cirrhosis or severe cardiovascular disease). Indigo carmine dye staining and electronic magnification was used in all cases, with endoscopic ultrasonography when indicated. 56 EMR-s were performed. The histological results on the biopsy and resected specimens were analyzed.
The morphology of the lesions was type I in 20, type IIa in 35, and type IIa-IIc in 1 case. The diagnosis at first biopsy was in situ carcinoma in 3, adenoma with no dysplasia in 19, adenoma with low-grade dysplasia in 2, adenoma with moderate-grade dysplasia in 6, adenoma with high-grade dysplasia in 7, and hyperplastic lesion in 17 cases. The histology of EMR revealed in situ carcinoma in 5, carcinoid in 1, gastrointestinal stromal tumor in 1, adenoma with no dysplasia in 14, adenoma with low-grade dysplasia in 3, adenoma with moderate-grade dysplasia in 9, adenoma with high-grade dysplasia in 1, hyperplastic lesion in 21, and no diagnosis in 1 case. However, the moderate- and high-grade dysplasia was diagnosed in different cases with the two methods. EMR was considered complete in all but 1 case. A Nd YAG laser was used in this patient with in situ carcinoma, where the resection margin was not free of cancer cells. Bleeding occurred in 3 cases; 1 required transfusion and had pneumonia postoperatively. There were no gastric cancer-related deaths during the median follow-up of 33 (1-90) months. In the follow up period we could not observe gastric malignancy in the previously hyperplastic polyp cases. Among adenoma cases one recurrence was seen in the same place and one in another location. One hyperplastic residuum occurred and in one case adenoma has grown in the same place.
EMR, a facile and useful diagnostic and therapeutic technique, appears very safe in terms of complications even in patients with comorbidities. Biopsy is generally unreliable to diagnose gastric adenoma. Lesions should be fully resected by EMR for a final diagnosis and (depending on the lesion size and type) possibly definitive treatment.
内镜下黏膜切除术(EMR)是胃腺瘤和早期胃癌广泛应用的治疗方法,但匈牙利尚无关于其应用的数据。本研究旨在评估EMR的诊断和治疗效果。
1994年至2005年期间研究了44例患者(30例女性,14例男性,平均年龄:67岁);33例有严重合并症(肝硬化或严重心血管疾病)。所有病例均采用靛胭脂染色和电子放大,必要时行内镜超声检查。共进行了56次EMR。对活检和切除标本的组织学结果进行分析。
病变形态为I型20例,IIa型35例,IIa-IIc型1例。首次活检诊断为原位癌3例,无发育异常的腺瘤19例,低级别发育异常的腺瘤2例,中级别发育异常的腺瘤6例,高级别发育异常的腺瘤7例,增生性病变17例。EMR组织学显示原位癌5例,类癌1例,胃肠道间质瘤1例,无发育异常的腺瘤14例,低级别发育异常的腺瘤3例,中级别发育异常的腺瘤9例,高级别发育异常的腺瘤1例,增生性病变21例,1例未明确诊断。然而,两种方法诊断中级别和高级别发育异常的病例不同。除1例患者外,所有EMR均视为完整切除。该原位癌患者使用了Nd YAG激光,切除边缘有癌细胞残留。3例发生出血;1例需要输血且术后发生肺炎。中位随访33(1-90)个月期间无胃癌相关死亡。随访期间,我们未观察到先前增生性息肉病例发生胃恶性肿瘤。腺瘤病例中,1例在同一部位复发,1例在另一部位复发。出现1例增生性残留,1例腺瘤在同一部位生长。
EMR是一种简便且有用的诊断和治疗技术,即使在合并症患者中,并发症方面也似乎非常安全。活检通常难以可靠诊断胃腺瘤。应通过EMR完整切除病变以进行最终诊断,并(根据病变大小和类型)可能进行确定性治疗。